Literature DB >> 18645137

Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.

Elisabeth Mazoyer1, Odile Enjolras, Annouk Bisdorff, Jérome Perdu, Michel Wassef, Ludovic Drouet.   

Abstract

OBJECTIVE: To investigate the clinical characteristics of venous malformation of the limbs and trunk and known but poorly appraised associated coagulation disorders. Venous malformations are ubiquitous, slow-flow vascular anomalies known to be occasionally painful because of thrombotic episodes inside the lesion.
DESIGN: Large case series, with screening of accepted standard coagulation tests.
SETTING: Ambulatory multidisciplinary clinics for vascular anomalies. PATIENTS: This 2-year study (2003-2005) included 118 patients with clinical, radiological, and biological features informative for better defining venous malformation and associated coagulation abnormalities. MAIN OUTCOME MEASURES: The primary outcome was coagulation disorders associated with VM. Secondary measures include anatomic location, extent of lesion, localized pain, and impaired motion.
RESULTS: The mean age of patients was 27 years, and there was a female preponderance of 64%. The venous malformation involved the upper extremity, lower extremity, and trunk in 30%, 58%, and 36% of patients, respectively; it was plurifocal in 22%. Intralesional pain (in 92% of patients) had a higher frequency in female (63%) than in male (47%) patients. Tissular involvement concerned the skin (65%), muscle (73%), bone (13%), joints (12%), and viscera (9%). According to our severity scoring system, cases of less gravity had a score of 2 or 3 (52%), cases of intermediate severity had a score of 4 or 5 (32%), and cases of major severity had a score of 6 to 9 (10%). The most frequent blood coagulation abnormality was a high plasma D-dimer level (> 0.5 microg/mL) (58% of patients), which was correlated with muscle involvement and high severity score and was more frequent in women. The factor VIII-von Willebrand factor complex was documented in 84 patients, and plasma von Willebrand factor level was decreased (<60%) in 23 (27%) of them; 10 of the 84 patients (12%) had more notably decreased levels (<50%).
CONCLUSIONS: This study of a large case series of patients with pure venous malformation in the limbs and/or trunk highlights muscle involvement and frequency of pain. It validates that coagulation disorders, present in 58% of our patients, create thrombotic painful events. Under certain circumstances, these disorders entail a risk of hemorrhage because of the progression of localized intravascular coagulopathy to disseminated intravascular coagulopathy.

Entities:  

Mesh:

Year:  2008        PMID: 18645137     DOI: 10.1001/archderm.144.7.861

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

Review 1.  Venous malformation: update on aetiopathogenesis, diagnosis and management.

Authors:  A Dompmartin; M Vikkula; L M Boon
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

2.  Ischaemia due to a vascular malformation causing focal myositis.

Authors:  Nuha Marwan Alkhawajah; Tim-Rasmus Kiehl; Vera Bril
Journal:  BMJ Case Rep       Date:  2014-08-25

3.  Common and specific effects of TIE2 mutations causing venous malformations.

Authors:  Marjut Nätynki; Jaakko Kangas; Ilkka Miinalainen; Raija Sormunen; Riikka Pietilä; Julie Soblet; Laurence M Boon; Miikka Vikkula; Nisha Limaye; Lauri Eklund
Journal:  Hum Mol Genet       Date:  2015-08-28       Impact factor: 6.150

Review 4.  Low molecular weight heparin biosimilars: how much similarity for how much clinical benefit?

Authors:  Ludovic Drouet
Journal:  Target Oncol       Date:  2012-01-25       Impact factor: 4.493

5.  Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation.

Authors:  Christophe Vandenbriele; Thomas Vanassche; Marijke Peetermans; Peter Verhamme; Kathelijne Peerlinck
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

6.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

7.  MRI phenotypes of localized intravascular coagulopathy in venous malformations.

Authors:  Kevin S H Koo; Christopher F Dowd; Erin F Mathes; Kristina W Rosbe; William Y Hoffman; Ilona J Frieden; Christopher P Hess
Journal:  Pediatr Radiol       Date:  2015-07-05

Review 8.  Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment.

Authors:  John L Nosher; Philip G Murillo; Mark Liszewski; Vyacheslav Gendel; Christopher E Gribbin
Journal:  World J Radiol       Date:  2014-09-28

9.  Popliteal Fossa Pain in 24 Year-old Female.

Authors:  Kwan Woong Choi; Kyung Bong Yoon; Duck Mi Yoon; Do Hyeong Kim
Journal:  Korean J Pain       Date:  2012-10-04

10.  Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.

Authors:  Elisa Boscolo; Nisha Limaye; Lan Huang; Kyu-Tae Kang; Julie Soblet; Melanie Uebelhoer; Antonella Mendola; Marjut Natynki; Emmanuel Seront; Sophie Dupont; Jennifer Hammer; Catherine Legrand; Carlo Brugnara; Lauri Eklund; Miikka Vikkula; Joyce Bischoff; Laurence M Boon
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.